Ledger.Open graph →
SEC Form D · filed October 21, 2024

OnKure Therapeutics, Inc

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

J. Shainline · Boulder, COExec · DirectorValerie M. Jansen · Boulder, CODirectorIsaac M. Manke · Boulder, CODirectorJason Leverone · Boulder, COExecSamuel Agresta · Boulder, COExecDylan Hartley · Boulder, COExecEdward T. Mathers · Boulder, CODirectorR. M. Carruthers · Boulder, CODirectorMichael G. Grey · Boulder, CODirectorAndrew J. Phillips · Boulder, CODirectorNicholas Saccomano · Boulder, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗